← Back to FR Documents
Final Rule

Medical Devices; Quality System Regulation Amendments; Correction

Final rule; correction.

📖 Research Context From Federal Register API

Summary:

The Food and Drug Administration (FDA or Agency) is correcting a final rule that appeared in the Federal Register on February 2, 2024. In that final rule, FDA amended the device current good manufacturing practice (CGMP) requirements of the Quality System (QS) regulation to harmonize and modernize the device CGMP. FDA is correcting an editorial error that inadvertently omitted a definition in the codified of the final rule. This action is editorial in nature and is intended to ensure the accuracy and clarity of the Agency's regulations.

Key Dates
Citation: 89 FR 82945
Effective February 2, 2026.
Public Participation
0 comments 17 supporting docs
View on Regulations.gov →

In Plain English

What is this Federal Register notice?

This is a final rule published in the Federal Register by Health and Human Services Department, Food and Drug Administration. Final rules have completed the public comment process and establish legally binding requirements.

Is this rule final?

Yes. This rule has been finalized. It has completed the notice-and-comment process required under the Administrative Procedure Act.

Who does this apply to?

Final rule; correction.

When does it take effect?

This document has been effective since February 2, 2026.

📋 Related Rulemaking

This final rule likely has a preceding Notice of Proposed Rulemaking (NPRM), but we haven't linked it yet.

Our system will automatically fetch and link related NPRMs as they're discovered.

Document Details

Document Number2024-23701
FR Citation89 FR 82945
TypeFinal Rule
PublishedOct 15, 2024
Effective DateFeb 2, 2026
RIN0910-AH99
Docket IDDocket No. FDA-2021-N-0507
Pages82945–82945 (1 pages)
Text FetchedYes

Agencies & CFR References

CFR References:

Linked CFR Parts

PartNameAgency
21 CFR 820 Quality System Regulation... -

Paired Documents

TypeProposedFinalMethodConf
No paired documents

Related Documents (by RIN/Docket)

Doc #TypeTitlePublished
2024-01709 Final Rule Medical Devices; Quality System Regulati... Feb 2, 2024

External Links

⏳ Requirements Extraction Pending

This document's regulatory requirements haven't been extracted yet. Extraction happens automatically during background processing (typically within a few hours of document ingestion).

Federal Register documents are immutable—once extracted, requirements are stored permanently and never need re-processing.

Full Document Text (416 words · ~3 min read)

Text Preserved
<RULE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>Food and Drug Administration</SUBAGY> <CFR>21 CFR Part 820</CFR> <DEPDOC>[Docket No. FDA-2021-N-0507]</DEPDOC> <RIN>RIN 0910-AH99</RIN> <SUBJECT>Medical Devices; Quality System Regulation Amendments; Correction</SUBJECT> <HD SOURCE="HED">AGENCY:</HD> Food and Drug Administration, HHS. <HD SOURCE="HED">ACTION:</HD> Final rule; correction. <SUM> <HD SOURCE="HED">SUMMARY:</HD> The Food and Drug Administration (FDA or Agency) is correcting a final rule that appeared in the <E T="04">Federal Register</E> on February 2, 2024. In that final rule, FDA amended the device current good manufacturing practice (CGMP) requirements of the Quality System (QS) regulation to harmonize and modernize the device CGMP. FDA is correcting an editorial error that inadvertently omitted a definition in the codified of the final rule. This action is editorial in nature and is intended to ensure the accuracy and clarity of the Agency's regulations. </SUM> <EFFDATE> <HD SOURCE="HED">DATES:</HD> Effective February 2, 2026. </EFFDATE> <FURINF> <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD> Laurie Sternberg, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5517, Silver Spring, MD 20993-0002, 240-402-0425. </FURINF> <SUPLINF> <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD> In the <E T="04">Federal Register</E> of February 2, 2024 (89 FR 7496), FDA published a final rule that amended the device CGMPs requirements in 21 CFR part 820. The preamble indicated that the definition for “batch” or “lot” was set forth at § 820.3 (21 CFR 820.3) but the definition for “batch” or “lot” was inadvertently omitted from the codified portion of § 820.3 in the final rule. FDA is, therefore, correcting the codified for § 820.3 to include the definition of “batch” or “lot” as was intended and to be consistent with the preamble of the final rule. In FR Doc. 2024-01709 appearing on page 7524 in the <E T="04">Federal Register</E> of Friday, February 2, 2024 (89 FR 7496), the following correction is made: <SECTION> <SECTNO>§ 820.3 </SECTNO> <SUBJECT>[Corrected]</SUBJECT> </SECTION> <REGTEXT TITLE="21" PART="820"> 1. On page 7524, in amendment number 4, in the first column, in paragraph (a) of § 820.3, the definition for “Batch or lot” is added in alphabetical order to read as follows: “ <E T="03">Batch</E> or <E T="03">lot</E> means one or more components or finished devices that consist of a single type, model, class, size, composition, or software version that are manufactured under essentially the same conditions and that are intended to have uniform characteristics and quality within specified limits.” </REGTEXT> <SIG> <DATED>Dated: October 7, 2024.</DATED> <NAME>Kimberlee Trzeciak,</NAME> Deputy Commissioner for Policy, Legislation, and International Affairs. </SIG> </SUPLINF> <FRDOC>[FR Doc. 2024-23701 Filed 10-11-24; 8:45 am]</FRDOC> </RULE>
This text is preserved for citation and comparison. View the official version for the authoritative text.